Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemiaDavide Rossi, Gianluca Gaïdano, Pietro Bulian et al.|Blood|2015Cited by 215
Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia.Davide Rossi, Marco Ladetto, Chiara Lobetti Bodoni et al.|Blood|2008Cited by 1
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow‐upPaola Ghione, Simone Ferrero, Elisa Genuardi et al.|British Journal of Haematology|2017Cited by 1